Acute chest pain is a common symptom that brings patients to the emergency department. Despite being a common presentation, it remains a complex clinical challenge due to its diverse etiology, which ranges from benign conditions to life-threatening diseases such as acute coronary syndrome (ACS), pulmonary embolism, and aortic dissection. The diagnostic approach to acute chest pain requires a thorough understanding of the clinical presentation, risk factors, and diagnostic testing. This article aims to provide a comprehensive approach to diagnosing acute chest pain in clinical practice.
Acute chest pain can present with varying characteristics that can give clues to its etiology. The clinician should obtain a detailed history, focusing on the nature, location, radiation, associated symptoms, and precipitating factors of the pain. It is also important to consider the patient's age, sex, and existing comorbidities as these can influence the likelihood of certain diagnoses.
Recognizing the risk factors for life-threatening causes of chest pain is crucial in the diagnostic process. These include age above 65, male sex, smoking, hypertension, hyperlipidemia, diabetes, family history of premature coronary artery disease, and known coronary artery disease. A thorough risk assessment can guide further diagnostic testing and management decisions.
Diagnostic testing for acute chest pain includes electrocardiogram (ECG), chest radiograph, and cardiac biomarkers. ECG is the first-line investigation and can reveal findings suggestive of ACS, such as ST-segment elevation or T wave inversion. Chest radiograph can help identify non-cardiac causes of chest pain, such as pneumonia or pneumothorax. Cardiac biomarkers, particularly troponins, are highly sensitive and specific for myocardial injury and are essential in diagnosing ACS.
Clinical decision rules, such as the HEART score and the GRACE score, have been developed to aid in the risk stratification and management of patients with acute chest pain. These tools incorporate clinical variables, ECG findings, and cardiac biomarkers to predict the likelihood of major adverse cardiac events. They have been validated in multiple studies and can help guide decision-making in this complex clinical scenario.
Diagnosing acute chest pain requires a systematic approach that includes a thorough history, physical examination, risk assessment, and appropriate diagnostic testing. Clinical decision rules can assist in risk stratification and guide management decisions. A high index of suspicion for life-threatening causes is always necessary, given the potential for catastrophic outcomes. Continued research and education are needed to further refine our diagnostic approach to this common but challenging clinical presentation.
1.
First-Line Combination for Bladder Cancer Not Eligible for Cisplatin Just Misses Positive Outcome.
2.
New drug combination shows particularly good results in patients with HPV-negative head and neck cancer
3.
Polatuzumab Vedotin Boosts Survival in Relapsed DLBCL
4.
A First in Total Larynx Transplant; 'Sniffing' Out Lung Cancer; Gen X Cancer Toll
5.
In a clinical trial, "3D mammography" nearly reduces the incidence of breast cancer between two screening exams.
1.
Transforming Cancer Care: CAR T-Cell Therapy for Relapsed/Refractory NHL and ALL
2.
Unlocking the Key to Treating Lymphoma: New Innovations in Cancer Research
3.
Unlocking the Mystery of Basilar Artery Stroke: A New Approach to Treatment
4.
Quality of Life Optimization in Long-Term Cancer Survivorship
5.
Molecular Matching for Individualized Blood-Disorder Therapy
1.
International Conference on Oncology, Cancer Prevention and Public Health
2.
International Conference on Cancer Nursing and Rehabilitation Strategies
3.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
4.
International Conference on Innovations in Critical Care for Oncology and Cardiology
5.
International Symposium on Oncology, Cardiology and Critical Care Innovations
1.
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
4.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
5.
How Nutrition Can Support Patients During Cancer Care
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation